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Martha Rose Staeheli, PhD 
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Background: Urban, underserved populations experience considerable disparities 
in the screening, prevention, and treatment of chronic disease, including behavioral 
health disorders.  Screening patients for such problems is widely recommended, yet 
is challenging to do in a brief primary care encounter, particularly for this complex 
patient population.  Electronic risk screening provides one method of eliminating 
disparities in the identification of risks, while limiting burden on providers.   
Objectives: 1) Screening data were compared to EHR data to assess differences in 
the prevalence of 12 risk factors and clustering of risks; 2) Patients screening 
positive for behavioral health problems were followed to determine rates of follow-up 
care, and the rate of newly identified cases in the intervention group; and 3) 
Successes and challenges in the implementation process were reviewed. 
Design: A quasi-experimental design was used to assess prevalence rates of 12 
health risks using an electronic tablet-based screening questionnaire. 
Sample: Intervention (n=473) and control (n=260) patients were selected from two 
urban, safety net primary care practices in Connecticut, the majority of whom were 
non-white and using public insurances.   
Results: There was a statistically significant increase in the identified prevalence 
rates of health risks in the intervention group compared with the control, but most 
patients had more than one medical risk.  For behavioral health disorders in one 
clinic, follow up rates were statistically significantly higher in the intervention group 
Martha Rose Staeheli-  University of Connecticut, 2015 
relative to controls, but were low overall.  While the risk screening intervention was 
largely successful, challenges included: integration of technological environments, 
limited clinical resources, and barriers in clinic workflow.   
Conclusions: This tablet-based electronic screening tool identified higher rates of 
disorders than have been previously reported for this population.  Electronic risk 
screening using patient-reported outcome measures offers an efficient approach to 
improving the identification of behavioral health problems, improving rates of follow-
up care, and establishing population public health surveillance.  Study-based 
recommendations are made for the successful future implementation of mHealth 
screening, including: integration of technological systems, establishment of a critical 
care pathways, inclusion of all levels of staff on workflow process development, 
identification of a project champion, and development of standing orders to improve 
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CHAPTER ONE: Introduction 
 
Racial, ethnic, and socioeconomic disparities in primary healthcare access 
and outcomes are well documented, particularly in urban populations, and are a 
growing focus of healthcare reform initiatives like the Affordable Care Act (DHHS, 
2015).  Health disparities are due to a number of complex systemic and psychosocial 
issues, including healthcare access, insurance and financial issues, the number and 
complexity of medical issues including chronic diseases, provider cultural 
competence, provider biases, and patient adherence (AHRQ, 2008; AHRQ, 2015a; 
CDC, 2013). 
To address some of these concerns, the principal agenda for improving the 
health of the American people, Healthy People 2020, has three overarching goals: to 
improve the quality and length of life through prevention and promotion of healthy 
behaviors, to create healthy environments, and to achieve health equity in 
underserved communities (DHHS, 2010).  These goals are echoed in Achieving the 
Promise  (New Freedom Commission, 2003), which supports the integration of 
behavioral health care into primary care to promote health and reduce disparities.  
Improved behavioral health treatment is critical to addressing racial and ethnic 
disparities in health, as behavioral health disorders may be both more prevalent and 
less recognized and treated in these communities, and are often co-morbid with 
serious physical health concerns ((Surgeon General, 1999; Surgeon General, 2001; 
Larson, Belue, Schlundt, & McClellan, 2006; Yamada & Brekke, 2008).   
 
In the US, primary care remains the best, and sometimes only, gateway to 
treatment for a variety of complex medical, behavioral health and psychosocial 
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issues.  Although the passage of the Affordable Care Act (ACA) has ensured that 
90% of Americans now have health insurance, best estimates indicate that around 
24% of people in the US still do not have a specific and consistent source of primary 
care (Kaiser Family Foundation, 2015; DHHS, 2010).  Those who do not have 
primary care access or insurance are disproportionately non-White, poor, recent 
immigrants, elderly, or more likely to have chronic diseases or disabilities, and are 
often living in Medically Underserved Areas or classified as vulnerable populations  
(AJMC, 2006; HRSA, undated). 
Moreover, disparities data indicate that some health care disparities are 
increasing, rather than decreasing, which is an alarming finding given the degree of 
healthcare reform and current and projected growth rates for many of these 
population groups  (AHRQ, 2008; AHRQ, 2015a; ADA, 2015).  This is particularly 
true in the area of chronic disease identification and treatment (AHRQ, 2015a; CDC, 
2013).  While half of all Americans burdened by chronic disease, and a quarter with 
more than one chronic condition (Ward, Schiller, & Goodman, 2014), the rate of 
chronic disease varies greatly by race; 51% of Hispanics and 46% of African 
Americans have a chronic disease, compared with 23% of Whites  (AHRQ, 2015a). 
The management and treatment of these chronic diseases accounts for over three 
quarters of Medicare spending and occurs mainly in a primary care setting (CMMS, 
2012).  Given the magnitude of this issue, preventing and treating these conditions 
are among the greatest and most costly challenges facing primary care (Grossman, 
Legedza, & Wee, 2008; Paul et al., 2013; Ward, Schiller, & Goodman, 2014).   
In addition to a higher prevalence of chronic disease, patients in urban safety 
net settings are at even greater risk for death and disability as a result of these 
diseases (AHRQ, 2015a; CDC, 2013; NACHC, 2009).  Recent studies indicate that 
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African Americans and Hispanics have higher age-adjusted rates of mortality from 
cardiovascular disease and hypertension than do Whites (AHRQ, 2008; Peterson, 
Shaw, & DeLong, 1997) and lower screening rates and higher death rates from 
HIV/AIDS and colorectal, prostate, cervical and breast cancers (AHRQ, 2015a; L. 
Anderson et al., 2003; Bach, Pham, Schrag, Tate, & Hargraves, 2004; Shavers & 
Brown, 2002).  Non-White Hispanic and African American populations are at greater 
risk for diabetes (around 13%) compared with Whites (7.6%), and are considerably 
more likely to experience complications of diabetes, including lower limb 
amputations, retinopathy, kidney failure, and death (ADA, 2015; Cefalu & Hill 
Golden, 2015; CDC, 2014).  Dental caries, the most prevalent chronic health 
condition among American children (DHHS, 2000), disproportionately afflict 
minorities and those whose caregivers are of low socioeconomic status (Edelstein, 
2002; Montero, Douglass, & Mathieu, 2003; Shiboski, Gansky, Ramos-Gomez, & et 
al., 2003; Tang, Altman, Robertson, & et al., 1997).   
Patients in urban safety net settings are also more likely to receive a poorer 
quality of care.  Comparatively few physicians provide care in African American 
communities and those who work in clinics serving greater than 30% minority 
patients have less access to supplies, specialists, examination rooms and diagnostic 
equipment (Bach et al., 2004).  Racial minorities are, on average, referred less often 
to specialty clinicians for follow up than are Whites, even when socioeconomic 
status, insurance status and health status are held statistically constant (L. 
Anderson, Scrimshaw, Fullilove, Fielding, & Normand, 2003).  And while these 
populations receive less necessary medical care, they also receive more 
unnecessary health procedures like amputations, orchiectomies, and avoidable 
hospitalizations (Fiscella, Franks, Gold, & Clancy, 2000; Gawande, 2015). 
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A major barrier to the provision of quality care for poor, minority populations is 
the number and complexity of medical issues such patients present, coupled with the 
limited duration of a typical patient encounter with a primary care physician and 
limited provider staffing (Fiscella & Epstein, 2008; NACHC, 2009).  Patients in these 
clinics are more likely to be depressed, have chronic pain, substance abuse and 
more medically and psychosocially complex lives (Bach, Cramer, Warren, & Begg, 
1999; Bach et al., 2004; Varkey et al., 2009).  Even when medical needs are 
identified and treated appropriately by clinicians, poorer or traditionally marginalized 
patients have additional barriers to receiving effective care due to lack of cultural 
sensitivity, more toxic environmental exposures, lack of preventive care, cost of 
prescriptions, inability to take time off from work and finding appropriate 
transportation to primary care and specialty visits, as well as meeting Medicaid, 
Medicare and ACA insurance deductibles (AHRQ, 2008; AHRQ, 2015a; L. Anderson 
et al., 2003; Betancourt, Carrillo, Green, & Maina, 2004).  Often these patients are 
then discharged from care for non-adherence to treatment regimens or because the 
services they require are not reimbursable at a high enough rate (Kleinsinger, 2010). 
These barriers to care can give providers the impression that patients are “non-
compliant” or “difficult to treat,” even when patients are motivated to participate in 
their own medical care (Kleinsinger, 2010; Roter et al., 1998).   
 
One major barrier to better health for medically underserved patients is the 
estimated 50% of behavioral health needs that remain undiagnosed (New Freedom 
Commission, 2003; DHHS, 2001; WHO, 2008).  For much of the US, primary care 
settings have become the first and only entryway for addressing the needs of the 
one in four adults with a diagnosable behavioral health condition (Surgeon General, 
The Integration of Behavioral Health in Urban Primary Care 
 5 
1999; New Freedom Commission, 2003).  This is particularly true in urban clinics 
that disproportionately serve racial and ethnic minorities, the poor, immigrants, and 
the chronically ill (AHRQ, 2003; Grossman et al., 2008; Sandoval et al., 2010).  
Because poor and urban populations also have more complex and serious medical 
needs, behavioral health disorders can be perceived as ancillary to or superseded by 
emergency conditions such as diabetes, hypertension, and cancer treatment (Gift, 
Strauss, Ritzler, & Kokes, 1988; Haughey, Calderon, Torres, Nazario, & Bijur, 2005; 
Larson et al., 2006).  However, when these conditions are not recognized and 
treated in marginalized populations, they have more devastating effects (compared 
with more affluent groups) on co-morbid medical conditions, overall family health, 
employment and education, and morbidity (Birnbaum et al., 2010; Braveman & 
Gruskin, 2003; Cameron, Lawton, & Reid, 2011; Downey, Zun, & Gonzales, 2009; 
McGibbon, Etowa, & McPherson, 2008; Pence, O'Donnell, & Gaynes, 2012). 
Although the Epidemiologic Catchment Area Study suggests that many 
behavioral health disorders may be similarly prevalent across racial and ethnic 
groups, these disorders are not equally identified and treated in Hispanics and 
African Americans versus Whites (see Simpson, Krishnan, Kunik, & Ruiz, 2007 for a 
review).  For example, 88% of African Americans living in the inner city have had 
exposure to severe trauma, compared with around 39% in the general population  
(Gillespie et al., 2009; Liebschutz et al., 2007).  As a result, from 23-46% of patients 
in community health center clinics are found to have post traumatic stress disorder 
(PTSD) compared with 7.8% in the general population, although 90% of PTSD in 
urban health settings is unrecognized by providers, which accounts for the range in 
estimates of its prevalence (Gillespie et al., 2009; Kessler, Mickelson, & Williams, 
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1999; Kessler & Wang, 2008; Liebschutz et al., 2007; Schwartz, Bradley, Sexton, 
Sherry, & Ressler, 2005).   
This type of disparity in risk exposure and treatment is also seen in 
prevalence of alcohol abuse and its treatment.  Native Americans and Whites are at 
the greatest risk of alcohol dependence (SAMHSA, 2014), but once dependence 
occurs, African Americans and Hispanics are more likely to have recurrent and 
persistent dependency issues (Chartier & Caetano, 2010; Nosek, Hughes, & 
Robinson-Whelen, 2008) and are less likely to have access to a physician for 
treatment (SAMHSA, 2007).  Ethnic minorities are also more likely to report more 
severe social and medical consequences from drinking (Mulia, Ye, Greenfield, & 
Zemore, 2009).  Several studies have identified a greater density of alcohol outlets 
such as bars and liquor stores in neighborhoods with high numbers of minorities, 
which is associated with higher levels of alcohol dependence and alcohol related 
violence (Chartier & Caetano, 2010; Young, Meryn, & Treadwell, 2008). 
In urban and underserved populations, behavioral health disorders like 
alcohol abuse and PTSD are often exacerbated by other psychosocial risks and are 
concomitant with other illnesses like depression (Christensen et al., 2005; Paul et al., 
2013; Pence et al., 2012; Rayburn et al., 2005).  Depression presents one of the 
greatest challenges to the US medical system.  Recent studies estimate that the 
economic burden of depression exceeds 210.5 billion dollars annually, and the 
impact of depression on the management and course of chronic diseases such as 
diabetes and heart disease is profound (Greenberg, Fournier, Sisitsky, Pike, & 
Kessler, 2015).   
While the rate of depression is around 9.5% in the general population, rates 
closer to around 19% have been found in poor urban clinics, with higher rates for 
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Hispanic patients (22.3%) (Olfson et al., 1997; Olfson et al., 2000).  However, 30-
66% of people in primary care centers who are depressed or anxious remain 
undiagnosed, compared to 10% in Whites, particularly if they are elderly, African 
American or Medicaid recipients (Harman, Schulberg, Mulsant, & Reynolds, 2001).  
African Americans are one third as likely to discuss depression with their primary 
care doctors compared to Whites, and only two thirds of African Americans who 
express emotional distress are diagnosed as depressed, compared to 90% of White 
patients (Ghods et al., 2008).  The race of the physician, not that of the patient, 
determines whether a depression diagnosis would result when the physician is 
presented with a patient’s depressive symptoms; White physicians diagnose 
depression in African American patients more often than do African American 
physicians (McKinlay, Lin, Freund, & Moskowitz, 2002).  This is complicated by the 
fact that African Americans are more likely to be treated by African American 
physicians than are Whites  (Laveist & Nuru-Jeter, 2002).   
Although around 50-90% of people with depression recover, rates of 
treatment for and recovery from depression are notably lower for people in medical 
safety net populations (Surgeon General, 2000).  In the general population, one third 
of all people who are depressed never get treatment for this condition after being 
diagnosed, but for those who are non-White, between 50 and 70% do not receive 
mental health treatment after a depression diagnosis (Surgeon General, 2001; 
AHRQ, 2015a; Kessler et al., 1999; Kessler & Wang, 2008).  In fact, even for those 
low-income primary care patients who were identified as having major depression, 
62% still met criteria for depression after four years, compared with around 20% for 
Whites, reporting more visits to EDs and worse health and functioning, affecting 
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families, employment, and global health outcomes (Birnbaum et al., 2010; Watkins et 
al., 2009). 
Given the state of many primary care centers serving poor urban 
communities, there are often fewer referral resources for counseling, psychiatric 
consult, or other out-patient services, which is partly responsible for the low rate of 
treatment (Cabassa & Hansen, 2007; Sartorius et al., 2007; Thomas, Eberly, Smith, 
Neaton, & Stamler, 2005; Zayas, McKee, & Jankowski, 2004).  If behavioral health 
symptoms are complicated by substance abuse or a serious mental illness, patients 
may bypass community primary care services altogether, which may partly account 
for the increase in this population’s use of emergency department services and 
likelihood of imprisonment (Fogarty, Sharma, Chetty, & Culpepper, 2008; Osher, 
D’Amora, Plotkin, Jarrett, & Eggleston, 2012; Varkey et al., 2009). 
 
Preventive care, including screening, represents a key strategy in addressing 
healthcare disparities for urban, underserved populations, although these patients 
remain far behind in their access to and use of prevention services (Fiscella, Holt, 
Meldrum, & Franks, 2006; Fiscella & Holt, 2007; NACHC, 2009; Partnership for 
Prevention, 2007).  One approach to improving the identification and treatment of 
common, under-recognized mental and physical health conditions is to implement 
systematic screening procedures (or processes). The majority of screening initiatives 
have been implemented to identify single diseases, like colorectal cancers, 
cardiovascular disease or substance abuse (Aseltine, 2010; Bhat & East, 2015; 
Davila, Rajan, & Baron, 2006; Emmons et al., 2009; Murff, Peterson, Greevy, 
Shrubsole, & Zheng, 2007; Thomas et al., 2005).  Comprehensive screening 
remains a challenge, despite its potential benefits (Southern et al., 2014).  The US 
Prevention and Screening 
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Preventive Services Task Force (USPSTF) recommends screening protocols for 53 
medical conditions (AHRQ, 2015b) the completion of which, along with other 
preventive services, would require more than 7 additional hours a day per provider in 
primary care (Shires et al., 2012; Yarnall, Pollak, Østbye, Krause, & Michener, 
2003).  These challenges are particularly critical in clinics serving poor and minority 
patients, where resources are especially scarce and the incidence of such conditions 
is particularly high (Fiscella & Holt, 2007; Fiscella & Epstein, 2008; Partnership for 
Prevention, 2007).  As a result, screening often drops on the priority list of tasks that 
must be accomplished during a short visit, and nursing staff bears more of the 
burden of screening administration and delivery of preventive care, and care 
coordination (Institute of Medicine, 2010; D. Anderson, St. Hilaire, & Flinter, 2012; 
NACNEP, 2012).  
However, primary care may be the only opportunity for patients in safety net 
settings to have access to screening, identification and treatment for certain types of 
cancer, obesity, diabetes, and HIV and other chronic diseases.  As the first step in 
prevention, screening for chronic conditions is associated with an increase in 
patients’ health-promoting behaviors and health beliefs (Bankhead et al., 2003; 
Rasmussen et al., 2007).  Screening patients for illness and linking that screening to 
appointments with a provider results in higher life expectancy even years later 
(Rasmussen et al., 2007).  Likewise, screening for risky drinking in both community 
and clinic settings has been shown to be an effective approach to linking at-risk 
individuals to treatment and in reducing alcohol consumption (Dupre, Aseltine, 
Wallenstein, & Jacobs, 2004; Johnson, Kypri, & Attia, 2013; USPSTF, 2009).  Similar 
results have been observed with community and clinic-based screening for 
depression (Greenfield et al., 1997). 
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While some screening protocols, like those for cancer, diabetes, or asthma, 
require diagnostic tests or imaging, some of the greatest chronic disease risks and 
co-morbid factors require information that must come directly from the patient 
(Patient Reported Outcomes), relating either to patient symptoms (e.g., feelings of 
depression or anxiety), behavior (e.g., diet, exercise, smoking, or drinking), or 
experience (e.g., exposure to violence, poverty) (Deshpande PR, Rajan S, 
Sudeepthi BL, Abdul Nazir CP, 2011; Higgins & Green, 2011; McKenna, 2011).  For 
these risk and conditions, patient involvement in providing information using 
structured screening approaches is crucial.  mHealth initiatives are emerging tools in 
the identification and management of chronic and complex illness and can facilitate 
patient involvement in providing risk information that is responsive to patient 
experiences and needs, while eliminating issues of provider knowledge and 
attitudes, and accounting for time and personnel scarcity  (Lubetkin, Santana, Tso, & 
Jia, 2008; Southern et al., 2014).  Mobile technologies, like smart phones and 
wireless devises, are used in environments all over the world to enhance public 
health by facilitating provider-patient communication, recording health behaviors, 
delivering education, and increasing adherence to medical and behavioral therapies 
in a manner that is cost effective and efficient, with high patient and provider 
acceptance (Anglada-Martinez et al., 2015; Moore, Holaday, Meehan, & Watt, 
2015a; WHO, 2015; Kaiser Family Foundation, 2015; Hamine, Gerth-Guyette, Faulx, 
Green, & Ginsburg, 2015).  
An evolving focus of mHealth implementation research is on the facilitation of 
screening protocols to identify symptoms of single diseases, like cardiovascular 
disease, bipolar disorder, depression, and high blood pressure (Clifford et al., 2014; 
Screening and mHealth  
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Deneke, Schultz, & Fluent, 2014; McGillicuddy et al., 2013; Nicholas, Larsen, 
Proudfoot, & Christensen, 2015; Raghu, Praveen, Peiris, Tarassenko, & Clifford, 
2015; Surka et al., 2014).  In addition to symptom and risk tracking initiatives like 
these, mHealth tools and other health information technologies can aid clinical 
decision making by capitalizing on the time the patient spends in the waiting room, 
allowing providers to prioritize care in the clinical encounter (Anand, Carroll, & 
Downs, 2012; Fothergill et al., 2013; Smith, Skow, Bodurtha, & Kinra, 2013).  This 
has proven effective in pediatric populations where patients have efficiently provided 
risk data electronically, including risk behaviors, while waiting for appointments, 
decreasing burden for clinicians (Anand et al., 2012; Fothergill et al., 2013; Smith et 
al., 2013).  Aside from pediatric patients, the effectiveness of mHealth innovations on 
improving health outcomes is mixed and highly determined by patient access to and 
ease with information technology (Anglada-Martinez et al., 2015; Hamine et al., 
2015).  Though little research has been done with medically underserved 
populations in the United States, mHealth technologies may have potential to 
effectively engage, monitor, and assess patients that access and use healthcare in 
less traditional manners and settings (Hamine et al., 2015; Moore, Holaday, Meehan, 
& Watt, 2015b; Silva et al., 2015).   
 
This dissertation presents the results of a project funded by the Connecticut 
Health Foundation under the direction of Robert Aseltine, Ph.D. at UConn Center for 
Public Health and Health Policy. A computerized risk-screening tool was used to 
collect self-administered health screening measures in the waiting room prior to a 
scheduled visit; these data were then scored immediately and summarized in a risk 
profile that could be accessed by the primary care provider at the time of the clinical 
Purpose of this Project 
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encounter.  These screening results were compared to data derived from chart 
reviews of patients seen prior to the deployment of the screening intervention to (1) 
establish the rates of unrecognized and undiagnosed health problems in this patient 
population,  (2) determine whether increased recognition of behavioral health 
problems in the encounter was associated with appropriate treatment and follow-up 
of identified patients, and (3) describe lessons learned in the implementation of an 
electronic screening protocol in an urban primary care setting.
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CHAPTER TWO: Methods 
A quasi-experimental design was used to assess usability and effectiveness 
of an electronic, tablet-based screening questionnaire among adult primary care 
patients in an urban setting.  These tablet data were used to compare identified rates 
of commonly encountered conditions and needs among patients completing the 
tablet screening, compared to patients in that same clinic that did not.  Two 
community health center clinics participated in the study.  Risk conditions and needs 
assessed included obesity, smoking, fall risk, osteoporosis risk, sexually transmitted 
infection (STI) risk, alcohol abuse, depression, post traumatic stress disorder 
(PTSD), domestic violence, basic needs (risk for homelessness and food insecurity), 
dental care needs, and need for colonoscopy among adult primary care patients.   
 
Seven hundred thirty three patients participated in this project.  Screening 
results for 473 patients in the intervention group were compared to a control group of 
260 primary care patients who were seen at the same clinics in two weeks prior to 
the implementation of the risk screening intervention.  All participants were 18 years 
or older and current primary care patients at two urban ambulatory primary care 
health centers in Connecticut.  Demographic characteristics of patients participating 
in the study are presented in Table 1.  The majority of patients were non-White, 
middle-aged, female, and using public insurance.  At both clinics, all patients who 
had not previously completed the screening questionnaire and presented to the clinic 
for a physical exam, an urgent care visit, walk-in visit, routine follow up, or well visit 
were eligible for screening.  Patients were not eligible for the study if they spoke a 
language other than English or Spanish, had a disability that prevented completion of 
 
Study Design  
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the screen, were in acute medical distress, or were scheduled for brief encounters 
such as immunizations, BP or A1C checks, diabetic foot or retinopathy exams.   
The screening questionnaire portion of this project was designated by the 
University of Connecticut Health Center Institutional Review Board to be Quality 
Improvement work, and thus not subject to IRB review or informed consent 
processes.  Participants were assured that participation in the screening 
questionnaire was entirely voluntary, was a standard request the clinic made to all 
primary care patients and that refusal to participate in any part of the project did not 
affect the services they would receive at present or in the future.  All data from the 
screening questionnaire or from the medical chart/EHR were de-identified and 
presented only in the aggregate. 
 
This project was implemented at two primary care clinical sites in Connecticut, 
both serving patients from medically underserved populations.  Clinic A is located in 
Hartford, CT and funded as a unique university/ community hospital collaboration to 
address urban Hartford’s medical and social service needs.  In 2006, Clinic A saw 
11,000 patients for primary care visits, all of whom were below the Federal Poverty 
Line.  Half of these patients were Hispanic, 25% were African American, and 25% 
were White.  Only 10% had private health insurance, and a quarter of all patients 
were uninsured, with the remaining population relying on publicly funded health 
insurance such as Medicaid and Medicare.   
Clinic B in Norwalk, CT offers comprehensive primary medical, dental and 
behavioral health services for all ages. The center also provides assistance with 
application for public insurance and other support programs and is the hub for mobile 
dental services offered throughout Norwalk.  In 2010, Clinic B saw 5,000 patients for 
Settings 
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primary care visits, 95% of whom were below the Federal Poverty Line.  As of 2013, 
Whites were 20% of the total clinic population, Hispanics were 50%, African 
Americans were 25%; the remaining 5% were “Other.”   A quarter of all patients were 
uninsured, 8% were self-pay and the remaining population relied on publicly funded 
health insurance like Medicaid and Medicare.   
 
Prior to implementation of the project, all clinic staff members were trained on 
the need for comprehensive risk screening and preventive care, use of the tablet 
technology, the risk assessment tools and their interpretation, and collaborated in 
development of workflow processes.  Staff from both clinics, including receptionists, 
medical assistants (MAs), nurses, physicians, and administrators, were brought 
together multiple times prior to the implementation of the project to review project 
goals, to outline a workflow amenable to the clinic and its staff, and to address 
questions and concerns.  All staff members were encouraged to be active 
participants in designing the screening workflow and to engage in an iterative 
formative evaluation process throughout the project.  Additionally, champions of the 
risk-screening project were identified at both locations to take ownership of the 
intervention and the workflow process, and to serve as a contact point for staff 
questions or concerns.   
To begin the screening process, the receptionists, who were trained in all 
aspects of the project and supervised by project staff, entered patients’ medical 
record numbers into the tablet.  Patients then completed the screening 
questionnaire, in English or Spanish, in the waiting room or in a separate exam 
room.  An audio version using headphones in either language was also available in 
Procedures 
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the case of low literacy or visual disability.  Reception and project staffs were 
available to address any questions or concerns.   
For the intervention group, 473 clinic patients seen between July, 2012 and 
December, 2013 completed the electronic risk screening questionnaire and their 
results were compared to a control group of 260 primary care patients who were 
seen at the same clinics in two weeks prior to the implementation of the risk 
screening intervention.  In Clinic A, 327 patients were screened between July, 2012 
and September, 2013.  Due to the technological and logistical constraints on data 
collection, it was not possible to determine the number of eligible patients from which 
this group was drawn, nor did providers see the results of the screening 
questionnaire.  (Chapter Five reviews deviations from the proposed screening 
process in more detail).   
In Clinic B, 314 clinic patients seen between September and December 2013 
were asked by receptionists to complete the electronic risk-screening questionnaire 
in the waiting room after checking in for their appointment.  Screenings were 
completed with 146 of 314 eligible patients (see Figure 1 for an intervention flow 
chart).  Patients who did not complete the screening were typically seen during 
periods when the clinic was very busy or when receptionist coverage was limited.  At 
Clinic B, results and recommendations for referral or further follow-up were 
summarized on the tablet and made available to the clinician.  Providers were asked 
to review screening scores and to act according to their own clinical judgment.  All 
data, scores, and recommendations were kept confidential in a secured database 





The questionnaire instrument was compiled by the PI (Aseltine) and the 
project manager (Staeheli).  The tablet-based screening platform, designed by 
OpenClinica, LLC. and Dimagi, Inc, allowed self-reporting by patients using a touch-
screen Android tablet that supported English and Spanish versions of the 
instrument, as well as audio versions for patients with low literacy or vision 
impairment.  This instrument incorporated dynamic branch logic to capture detailed 
information triggered by prior responses where needed from patients (e.g., to 
navigate between the two tiers of the screening instrument).  The first tier of 
questions included 18 basic demographic and health risk questions – age, race and 
ethnicity, gender, marital/partner status, global health rating, height, weight, 
smoking, alcohol use, depression (2 questions), dental risk (2 questions), and 
financial and housing status (4 questions).  Based on patients’ responses to these 
initial questions, a series of follow-up questions were presented in tier 2 to determine 
patients’ risk status.  Completion of all screening questions took approximately 5-8 
minutes, depending on the number of tier 2 follow up questions.  For instance, 
patients would only be asked to complete the 4-item HITS domestic violence 
screening instrument at tier 2 if they reported having a spouse/partner in the tier 1 
questions.  This approach ensured that respondents were only asked to complete 
questions that were appropriate to their risk profile and resulted in a much more 
efficient data collection effort. 
Screening responses were transmitted through a secure wireless network to a 
secure server where they were automatically scored and analyzed for 
recommendations.  Results and recommendations were summarized on the tablet.  
At Clinic B, the results were manually entered into the clinic’s electronic health (EHR) 
Screening Instrument 
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record by a MA prior to the clinical encounter.  Due to technical barriers, medical 
providers did not see the screening results from Clinic A.  
 
Risk Screening Instrument 
The measures and data sources for the intervention and control groups at 
each clinical site are summarized in Table 2.  For the intervention group, the primary 
outcomes consisted of measured prevalence rates of risk dimensions as obtained 
through screening results obtained during the target appointment.  Where possible, 
standardized and validated measures in both Spanish and English were used to 
assess needs and risk of medical condition (Table 3).  Screening measures were 
scored according to rubrics set out by the original authors of the measures, and all 
measures’ scoring resulted in dichotomous variables indicating either the presence 
or absence of risk. 
For health domains in which validated measures were not available (e.g. 
dental health and basic needs), focus groups of professionals and experts were 
consulted to generate three questions each that would be indicative of the need for 
care.  All focus groups followed similar established methodologies for conducting 
focus groups and qualitative data analysis (Kitzinger, 1995; Morgan, 1996; 
Robinson, 1999).  In the resulting screening questions (see Table 3), a positive 
answer to any one of the three questions would result in a dichotomous positive 
screening result on the risk dimension.   
For the basic needs dimension, two focus groups were convened at a 
homeless shelter in New Haven, CT and led by an experienced qualitative 
researcher with expertise in homelessness. The groups’ charge was to determine 
three questions that could be asked in a primary care visit that would indicate pre-
Measures 
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homelessness or risk of food insecurity, resulting in either a referral to social work, 
case management, or further questions by the PCP.  The first focus group was 
conducted with five professionals working in the outreach and engagement of people 
who were homeless and in the management of the homeless shelter.  The second 
focus group was conducted with 12 people who were either currently or formerly 
homeless.  Each focus group was 1-2 hours long, notes were taken to record 
participants’ observations, and consensus summaries reached during the course of 
the group.  Potential questions were re-presented to both groups to check for 
accuracy and to determine final screening questions.   
The dental risk questions were determined similarly with two focus groups led 
by an experience dental researcher.  The groups’ focus was to determine three 
questions that could be asked in a primary care visit that would result in a referral to 
a dentist or dental hygienist.  The first focus group consisted of 8 advanced dental 
students at UConn Health Center.  A second group of 3 dental faculty members at 
UConn Health was similarly convened.  Themes from the discussion were 
summarized and consensus was reached during the course of the groups.  Results 
were then re-presented to both groups to ensure accuracy and both groups agreed 
upon screening questions.   
Data from Medical Records 
All medical/EHR records were systematically reviewed according to the 
process outlined below (1) to determine the presence of the risk/medical problem as 
captured in the target appointment, (2) to determine the presence of the risk/medical 
problem at any visit in the 6 months prior to the target appointment, and (2) to 
document any treatment or follow-up for these problems occurring in the target 
appointment or in the 6 months prior to the target appointment.  Any mention of 
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these problems in either the problem list or in the progress notes for any 
appointment occurring in the target appointment or 6 months prior to the target 
appointment resulted in a positive score for the problem.  A patient was considered 
to have received treatment or follow up for each of these problems if there was a 
notation that the provider had counseled the patient, scheduled a follow up 
appointment for the problem, made a referral to another provider, or prescribed 
medications. 
In addition, demographic characteristics for all patients were recorded, 
including age, gender, race, ethnicity, source of payment, and history of clinic visits. 
 
Medical records were reviewed for evidence of recognition or treatment of any 
of the risk conditions screened for in the intervention, as described above.  The 
project manager and trained research assistants reviewed all records using dual 
data entry techniques such that a minimum of two reviewers abstracted every chart.  
EHRs were reviewed for the intervention (n=146) and control groups (n=129) at 
Clinic B.  Paper medical records were reviewed for the control group at Clinic A 
(n=131).  However, given the volume of patients in the intervention group, the 
complexity of the record retrieval process and the limited staffing resources, it was 
not possible to collect medical record data for intervention patients at Clinic A.   
In accordance with accepted procedures (Gritsiouk, Hegsted, Gardiner, 
Merriman, & Dean Gubler, 2013; Liddy, Wiens, & Hogg, 2011; Panacek, 2007; Yawn 
& Wollan, 2005), cases in the control group were defined as patients having been 
seen in the clinic in the two weeks prior to the implementation of the screening 
intervention.  Chart review procedure guidelines were developed by the clinical and 
research teams, and the variables to be included in the review were careful defined. 
EHR and Chart Review Procedures 
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Consistent data recording was ensured by a didactic review of five charts by both 
reviewers, followed by separate review and reconciliation of 10 charts.  After each 
reviewer completed 30 reviews, consistency was again assessed and found to be 
acceptable, which represented 95% agreement and/or a kappa statistic of .75 or 
higher (Yawn & Wollan, 2005).  The PI, project manager, and the research team 
adjudicated the small number of coding discrepancies between reviewers. 
Prior to resolution of coding discrepancies inter-rater reliabilities were 
calculated for the entries for each risk factor and ranged between .97 and 1.0, 
indicating a very high level of reliability.  Because identification of and treatment for 
these disorders were relatively rare, we used the Gwet AC1 (Gwet, 2008) to assess 
inter-rater agreement.  In situations involving low prevalence, traditional measures of 
reliability, such as Cohen’s Kappa, can result in very low, or even negative, values 
when overall agreement is very high (Byrt, Bishop, & Carlin, 1993; Gwet, 2008). 
 
SPSS 22.0 statistical analysis software (SPSS, INC., Chicago, IL) was used 
to analyze all quantitative data.  Statistical approaches are described in the following 
chapters.  Significance tests were two-tailed (p ≤ .05).  
Analysis 
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CHAPTER THREE:  Use of mHealth Screening Technologies to Identify Risk 
Prevalence in Urban Primary Care 
 
The purpose of this study was to present overall results from the project and 
to compare screening results from the intervention group (n=473) to chart review 
data from the control group (n=260) in both Clinics A and B to: 1) define rates of 
unrecognized and undiagnosed chronic health conditions and risks, and 2) to 
determine risks that are associated with one another.   
 
Demographic characteristics of experimental groups from both clinical sites 
are presented in Table 1.  It is important to note that the demographic data for race 
and payer were limited for the control group at Clinic A, because those data were not 
always recorded in the paper medical charts.  Overall, the intervention and control 
groups shared a similar demographic profile, but chi square analysis demonstrated 
that both experimental groups had more women than men and more existing 
patients than new.  While both experimental groups were mostly non-White, there 
were statistically significantly more African Americans in the control and more 
Hispanics in the intervention.  Patients in the intervention condition were younger, 
and more likely to have public insurance. Patients at Clinic A were more likely to be 
older, African American and using public insurance.  
Table 4 presents the prevalence of risk factors identified in the intervention 
group using the tablet based screening, compared to the prevalence rates 
determined by chart review among those in the control group.  Using logistic 
regression analysis that controlled for clinical site, experimental group, gender, age 
and race, the intervention group had statistically significant higher detection rates for 
Results 
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every risk/medical condition when compared with the control group.  Alcohol abuse 
was significantly higher in the intervention group than in the control group, but 
prevalence varied by site, with higher rates of risky drinking in the control group at 
Clinic A (4.6%), than in the intervention group for Clinic A (2.4%) or the control group 
for Clinic B (2.3%).  Rates of risky drinking were significantly higher (8.2%) in the 
intervention group at Clinic B.  Dental needs, obesity, depression, basic needs and 
PTSD were the most common risks identified in the intervention group, with 
prevalence rates ranging between 32 - 56%.  By contrast, much lower levels of these 
same risks were identified in a review of charts among patients in the control group.  
The highest prevalence rates in controls were observed for obesity (21.5%) and 
smoking (15.4%).  The most striking contrasts between intervention and control 
patients involved basic needs, PTSD, and dental needs, which were rarely if ever 
observed in the charts of control patients, but had a substantial prevalence among 
intervention patients.  In addition, the risk of domestic violence was not observed in 
the chart review, but was detected in almost 5% of patients completing the tablet 
screening.   
Further analysis revealed that the prevalence of obesity, depression, domestic 
violence and osteoporosis among intervention patients varied by race (Table 5). 
African American patients were most likely to be obese.  Hispanic patients were 
most likely to be depressed, experience domestic violence and need osteoporosis 
screening.   
The number of conditions for which each patient was identified as being at 
risk was dramatically different depending on experimental group (Table 6).  Based 
on a review of their medical charts, the majority of patients (56.5%) in the control 
group had none of the risk factors assessed in this study.  In contrast, only 4.2% of 
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patients in the intervention group did not screen positive for any of the assessed 
risks.  The modal category among intervention patients was positive screening 
results for two risk factors (22.4%), and 53% of the intervention group screened 
positive for 3 or more risks or conditions. 
Analysis of the clustering of risks among patients in the intervention group 
was done using the Fisher's Exact test to examine the association between each 
pair of binary screening variables.  Table 7 presents the p-values resulting from 
these tests; to correct for multiple comparisons, the significance level was chosen to 
be 0.008, which controls for a false discovery rate of 5% (Benjamini & Hochberg, 
1995).  Thus, p-values less than 0.008 reflect statistically significant associations 
between pairs of risks.  The results presented in Table 7 indicate a statistically 
significant amount of covariation among certain risk factors.  These are depicted in 
Figure 2, where lines linking two risk factors or conditions reflect a statistically 
significant association after adjusting for multiple comparisons.  The two conditions 
most commonly linked with other risks were PTSD and depression, both of which 
were associated with positive screens for BMI, smoking, and basic needs.  Risk of 
domestic violence was also associated with basic needs, as well as risk for STI and 
alcohol abuse.  Risks for falls, and need for further osteoporosis and colon cancer 
screening, and dental needs were not significantly associated with other risk factors 
or conditions. 
  
This study demonstrated that our use of mobile technology to screen patients 
in health center settings serving patients in the medical safety net enabled us to 
identify much higher rates of health conditions and social and demographic risks 
than are typically identified in clinical encounters and recorded in patients’ records.  
Discussion 
 25 
Patients who completed the risk screening were found to have rates that were 
significantly higher than those in the control group for every single risk 
factor/condition for which they were screened.  Some conditions, like PTSD, were 
not identified at all in the control group, but were highly prevalent in the intervention 
group.  For the majority of the risks and conditions we assessed, prevalence rates 
were several times higher among intervention patients compared to controls.  The 
most common risk varied by race; White patients were most likely to be smokers, 
African Americans were most likely to have a BMI over 30, and Hispanics were most 
likely to be in need of dental care.  The majority of control patients did not have 
evidence of any of these risks or conditions in the target visit.  In contrast, over 95% 
of patients in the intervention group exhibited risk factors for one or more conditions, 
with a majority of those exhibiting between 1 and 4 risks.  Behavioral health 
conditions co-occurred at high rates, and tended to occur with socioeconomic deficits 
such as food insecurity and basic needs risk.   
 There have been many targeted interventions to increase screening on 
singular risk dimensions in primary care, such as colon cancer screening or 
depression screening, universal risk screening strategies that deliver a 
comprehensive profile of the prevalence of the most common risks seen in an urban 
primary care setting have been uncommon.  This study provides valuable insight into 
the needs of a traditionally underserved population in a comprehensive and holistic 
way, rather than “siloing” particular health risks.  Most patients in urban and 
underserved settings arrive at their primary care visits with multiple complex health 
concerns that may not be illuminated in an appointment for chronic disease 
management (e.g. diabetes, hypertension, asthma, etc) or for an acute concern (e.g. 
ear infection, injury, etc.), but which still appreciably impact the global health of 
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patients, their adherence to treatment regimens, and their ultimate health outcomes, 
as well as influencing workforce productivity, educational opportunities, and overall 
community health (DHHS, 2010; Paul et al., 2013; Ward et al., 2014).  Risks like 
basic needs, depression, and PTSD may not be the stated reason for the visit, and 
may not be identified during the visit, but may have a marked effect on patients’ 
ability to adhere to treatment protocols, and are conditions that make the 
management of chronic disease more costly and complex if left untreated (Paul et 
al., 2013; Ward et al., 2014). 
 While all populations are in need of more effective, efficient screening 
strategies, populations in the medical safety net have more pressing and complex 
unmet needs, exaggerated by disparities in access to and quality of care, as well as 
poorer health outcomes.  Though some issues of access have improved with the 
introduction of the ACA, the high deductibles associated with ACA insurance plans 
often exacerbate limits in access to appointments, medications and diagnostic tests 
(AHRQ, 2015a; L. Anderson et al., 2003; CDC, 2013).  Adopting universal screening 
has the potential to reduce those disparities by identifying risk in an evidence-based, 
non-biased way for all patients.  The identification of these areas of higher risk 
should improve outcomes for individual patients, but can also direct clinics to areas 
where preventive and care coordination strategies can be enacted to reduce overall 
disparity and improve outcomes.  In order to identify quality, cost, and disability 
ramifications, these risk data can also help public health authorities map implications 
for cost and disease development along a predictive timeline,.  These data also 
serve to create foundational arguments for appropriate funds to address the risks as 
identified in a preemptive mode, leading to cost savings, as well as improved 
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population health and improved economic, educational and quality of life outcomes 
for populations that have traditionally been at the margins. 
This has particular implications for the way primary care in safety-net settings 
is delivered, as this setting presents complex and multifaceted risk profiles to 
providers.  These risks include identifying factors that have previously been beyond 
the purview of the types of services delivered in primary care (e.g. basic needs like 
food insecurity or pre-homelessness or dental risk), and also identifying risks at 
much higher volume than clinics are used to addressing, both in the type of risk and 
in the volume of patients.  A more concrete understanding of this population’s health 
profile presents meaningful challenges to clinics, as patients with multiple risks 
require additional staff time, alteration of clinical workflow, referral resources, while 
presenting administrative and reimbursement challenges.  This type of screening 
technology provides data that allow clinical leadership to advocate for increased or 
targeted funding and to create environments that better meet the needs of these 
patients.  This would require allocating longer visit times for some patients, hiring 
staff to address particular needs in prevalence “hot spots” (such as community 
health workers and behavioral health professionals) and focusing staff and patient 
education around those needs.   
There were several limitations to this study.  Although every effort was made 
to identify validated measures to use in the screening questionnaire, there were 
some areas of risk (e.g. dental risk and basic needs) for which validated measures 
do not currently exist.  In these cases, we developed measures based on focus 
group feedback from experts.  Additionally, although BMI was included as an 
assessment of obesity, this is a controversial measure of health, and clinical sites 
reported that patients were, at times, unwilling or unable to accurately estimate their 
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weight and height.  Because of this, we determined that this factor is better 
objectively measured by MAs rather than relying on self report.  Additionally, there 
are substantial limitations on the ability of medical charts/EHRs to capture all 
elements of the clinical encounter; they therefore may underestimate risk factors 
identified and addressed in the visit. 
In an era where more attention is being brought to care coordination, patient 
centered medical homes, and preventive services, screening technology such as the 
one used in this project capture data on multiple dimensions in a way that is efficient 
for clinics, accurate and timely for providers, and reflects patients’ experiences and 
behaviors.  This project presents one method for obtaining those risk data that might 
otherwise not emerge in a clinical visit, leveraging technology to increase efficiency, 
accuracy, and acceptability in a clinic setting.  Having a more comprehensive picture 
of the health of patients, particularly for patients who have historically been 
underserved in healthcare, increases the likelihood that individuals will receive 
much-needed care and that overall health disparities will be identified and 
ameliorated. 
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CHAPTER FOUR: Using mHealth Technologies to Improve the Identification of 
Behavioral Health Problems in Urban Primary Care Settings 
 
The purpose of this chapter is to compare screening results at Clinic B (n= 
146) to data derived from chart reviews in control group patients (n=129) to 
determine: 1) the rates of unrecognized and undiagnosed behavioral health 
problems in this patient population, and 2) whether increased recognition of 
behavioral problems in the encounter was associated with appropriate treatment and 
follow-up.   
 
Data sources are presented in Table 8.  The demographic characteristics of 
participants are presented in Table 9.  Overall, patients in the intervention and 
control groups were similar.  A majority of patients were Hispanic.  Two thirds of 
patients were female, with half of patients receiving Medicare or Medicaid and a 
quarter uninsured.  Most had been patients in the clinic for longer than six months 
and had been seen by a clinic provider in the previous six months.  Statistically 
significant differences in the age distribution of intervention and control patients were 
observed with chi-square analysis, with a greater proportion of younger patients in 
the intervention group.  Demographic characteristics of patients seen in the clinic 
during the intervention period who did not complete the risk screening assessment 
are also presented in Table 9.  Those who did and did not complete the screening 
during the intervention period shared a similar demographic profile with the 
exception of race, with African American patients making up a larger percentage of 
patients who were not screened compared with patients who were screened.   
Results 
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Table 10 contrasts rates of behavioral health problems identified during the 
target appointment through patient screening (intervention group) with those 
identified by providers during the clinical encounter and recorded in the patient’s 
chart (control group) as a result of usual care.  Using logistic regression analysis with 
age as a covariate (because it was the only statistically significant demographic 
difference between the two groups) indicates that much higher rates of behavioral 
health problems were identified through patient screening than were identified by 
providers during the encounter.  Depression was over 5 times more likely to be 
identified among intervention as opposed to control patients (OR = 5.3, 95% CI = 
2.5, 11.3).  PTSD was unrecognized among patients in the control group, yet its 
prevalence in the intervention group exceeded 28% (OR = 105.6, 95% CI = 6.5, 
>999) and a Firth bias correction using a penalized likelihood estimation method was 
used to address separation issues (Firth, 1993).  Alcohol abuse was 3.5 times more 
likely to be identified among intervention patients, but this difference was not 
statistically significant because the number of cases was so small. There was no 
statistically significant difference between the intervention and control groups in 
identification of behavioral health disorders in the six months prior to the target 
appointment.   
Although patient screening resulted in much higher rates of identification of 
those with behavioral health problems, rates of documentation in patients’ EHRs of 
identified behavioral health issues resulting from those visits and rates of follow up 
care remained very low.  Screening results for one third of all patients in the 
intervention group were not entered into the patient records, probably due to time 
constraints.  Among these patients, only one patient, who had screened positive for 
depression, had that finding noted, and none of these patients received any follow up 
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care.  Table 11 presents rates of EHR documentation and follow-up care among the 
two-thirds of intervention patients whose screening results were entered into their 
medical records and reviewed by their provider. Among those screening positive for 
any of the three behavioral health disorders, few patients had their results included in 
the notes section of the EHR during the target appointment.  Even fewer had their 
screening result recorded in the EHR problem list, or received follow up treatment.  
Among patients screening positive for depression, 39% had their screening results 
included in the notes section of the EHR during the target appointment, 9% had their 
screening result included in the problem list, and only 18% were provided any follow-
up care.  In contrast, patients screening positive for alcohol problems and PTSD 
were even less likely to have had their screening results included in either the EHR 
notes or list, and only 2 patients screening positive for PTSD received follow up care. 
It should be emphasized that these low rates of documentation and follow-up were 
observed despite the fact that the vast majority if not all of the cases identified 
through screening were “new” cases, i.e., were not previously reflected in the 
patient’s EHR. 
 
In this study we demonstrate that automated, tablet-based screenings using 
validated, patient reported outcomes are effective in identifying previously 
unrecognized illness in an urban, underserved population. The tablet-based protocol 
identified substantially higher levels of alcohol abuse, depression and PTSD in 
comparison to a group of patients treated previously in the same clinic, even though 
the clinic routinely used the PHQ-9 to screen for depression.  To our knowledge, this 
is the first study demonstrating the effectiveness of electronic, patient-reported 
screening for identifying behavioral health problems in primary care settings.  
Discussion 
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This approach holds great potential for assisting clinicians in addressing the 
meaningful and often unrecognized behavioral health needs of patients that are 
typically seen in FQHCs and other safety net settings, as well as more affluent 
areas. However, our results also indicate that screening alone is not sufficient to 
ensure that patients receive adequate follow-up care, which is consistent the findings 
of previous research (Husky, Sheridan, McGuire, & Olfson, 2011; Miranda et al., 
2013; Unützer & Park, 2012; M. Weissman et al., 2010).  Even in a clinic routinely 
screening for, and addressing, behavioral health issues, newly identified behavioral 
health issues were not included in many patients’ problem lists, a critical portion of 
the medical record for codifying and monitoring patient health (Liddy et al., 2011; 
Yawn & Wollan, 2005).  Moreover, few of these patients were referred for treatment, 
despite on-site behavioral health specialists in this clinical setting.   
When presented with these findings, providers and staff identified several 
issues that might prevent patients from being successfully referred to behavioral 
health services. Providers observed that it was challenging to make “warm hand offs” 
when clinic schedules were too busy or staffing was limited, or when the behavioral 
health provider was not immediately available.  Providers also spoke about the 
challenge of talking with patients about “difficult “issues or finding language that 
“made sense” to patients, particularly if patients were members of a culture that 
particularly stigmatized these types of behavioral health issues or attributed their 
causes to factors outside of the patient (e.g. sin, evil, weak character, etc.) or if there 
was a language barrier. Several providers referred to resistance of patients to being 
identified with a behavioral health disorder, which included patients refusing 
additional follow up, saying they felt better after talking about it, had outside support, 
did not believe the screening results, or were embarrassed.  
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This study has several limitations.  First, the small sample size of patients in a 
single clinical setting limits the generalizability of these findings, and we were only 
successful in screening 47% of the eligible patients. Second, while our intervention 
group was demographically comparable to control patients, we had limited 
information on patients who declined to use the electronic tablet screening and why.  
Clinic staff was responsible for asking patients to complete the screening 
questionnaire, and information on reasons for refusal was not systematically 
collected.  Although this approach replicated the real-life workflow of the clinic, we 
cannot be sure that there are not some statistically significant demographic or health 
differences in patients who were not screened.  Third, the use of the patient chart as 
a proxy for the content of the clinical encounter can be problematic, as it may not 
fully reflect the content of the clinical encounter (Liddy et al., 2011; Yawn & Wollan, 
2005).   
Although screening is a critical first step for identifying patients at risk, it alone 
is not sufficient to ensure adequate care.  Recommendations to address the 
challenges to follow up are addressed more fully in Chapter Six. Future studies 
should seek to understand how such information could be integrated into a clinical 
workflow that supports clinicians in both recognizing and responding to the 
behavioral health needs of patients. A key element of successful screening 
interventions will be the integration of results into team-based function so that a team 
member is made accountable for reviewing, identifying unaddressed risks and acting 
on them.  Such data could also be useful to teams in following behavioral health 
outcomes over time by yearly repetition of the screening.  Despite its limitations, this 
study presents a promising approach to identifying previously unrecognized 
behavioral health problems in a challenging patient population and lays the 
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groundwork for future efforts to improve clinical outcomes. By collecting patient-
reported outcome measures during patients’ idle time in the waiting room, this 
approach addresses screening requirements in an efficient and pragmatic way and 
yields health information that is unlikely to be generated in a typical clinical 
encounter.   
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CHAPTER 5:  Lessons Learned in the Implementation of mHealth Risk 
Assessment in an Urban Primary Care Environment 
 
This paper reviews the process, successes, and challenges of implementing a 
tablet-based mHealth risk screening study in two community health center settings. 
 
The proposed screening process involved approaching every primary care 
patient presenting to the clinic when they registered at the front desk for their 
appointments.  Patients would be given a tablet on which they could complete the 
screening questionnaire, with assistance from reception staff if necessary.  
Screening results would then be tabulated automatically and presented as a risk 
screening profile that would be entered into the medical record and made accessible 
to providers during the clinical encounter, through a desktop icon. 
Table 12 presents the contrast between the proposed screening process and 
deviations in that process as actually implemented at the two clinics.  The two clinics 
in which this project was implemented represented vastly different urban primary 
care environments.  Clinic A serves as a teaching and training clinic for large hospital 
and university systems, with interns and residents cycling regularly through the clinic 
rotations.  Primary care services are offered, but ancillary services, like behavioral 
health or specialist care, are limited.  Paper patient records were used, wireless 
connectivity was limited, and front desk staff and nursing staff were limited.  While 
the staff was enthusiastic about the benefits of screening to their patients, the 
number of patients, reduced staffing due to budget constraints, a change in clinical 
leadership and limited time also overwhelmed them.  In this clinic, patients were 
given the tablets to complete the screen, and the tablet was handed to a nurse or 
Results:  Proposed Vs. Actual Intervention Process 
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MA after completion.  Given frequent personnel turnover, the lack of an EHR, and 
overwhelmed staff, primary care providers did not reliably see the results of the 
screening, nor did they enter those results by hand into their paper charts. Over the 
course of 91 days of screening, 327 patients completed screening.  Because of the 
disconnect between the scheduling and charting systems, it was impossible to 
determine who was an eligible patient at Clinic A. 
Clinic B is a smaller community health center site with two providers, two 
MAs, a nurse and two front desk staff who were enthusiastic about the opportunity to 
use technology for patient screening and who felt that they could implement the 
project by working out a collaborative process.  Primary care services were offered, 
with onsite behavioral health and dental care employing a “warm-handoff” method of 
referral in which the medical provider introduced the patient to the dentist or therapist 
to either make an appointment or be seen for immediate care.  EHRs were also used 
in this technology rich and adequately staffed clinic, but the EHR could not be 
configured to accept data imports from the risk screening tablet.  Patients were given 
the tablet in the waiting room, completed it with the help of front desk staff if needed, 
and handed the tablet to the MAs, who reviewed the results and entered them into 
the EHR for the provider to access during the appointment.  Over the course of 32 
screening days of the intervention, 146 patients (46.5%) out of 314 eligible patients 
completed the screening. 
 
Implementation of the screening protocol can be broken down into two 
process segments: screening patients and then addressing screening results so that 
patients benefit from them.  This pilot project demonstrated success in the first 
segment of the process, although the data collection process was severely 
Discussion 
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hampered by lack of wireless connectivity and data interoperability in the systems, 
which are discussed below. These challenges meant that some patients who were 
eligible to complete the screen were not able to, that there were periods of days or 
weeks when tablets were not used, times when staff were frustrated or over-
burdened, all of which impeded the collection of valuable data and made it difficult to 
determine whether the goals of the project were met. In the course of the 
intervention, 473 patients were screened for a variety of chronic disease risks and 
conditions, many for the first time.  Comparison to the control group demonstrated 
that the electronic risk-screening tool identified a substantially higher prevalence of 
health risks.  The screening results are presented in Chapter 3, but positive 
screening results led to follow up care for more individuals in the intervention group 
than in the control group, illuminated new service needs, and contributed to a more 
complete health profile of the clinics’ underserved, urban populations.   
Prior to the implementation of the electronic screening intervention, several 
potential impediments were identified by focus groups with clinic staff and project 
leadership: 1) patients would not be able or willing to complete the screening 
assessment, 2) tablets would be lost or stolen, and 3) staff would not accept a new 
screening protocol.  In fact, these concerns were unfounded.  The majority of 
patients approached to complete the screening assessment participated and were 
able to complete the assessment in around 5-8 minutes.  Additionally, not a single 
tablet from either clinic was lost or stolen.  Staff members created a numbering 
system for keeping track of tablets (e.g. Mr. F has Tablet 4) and patients were 
responsible about returning the tablets to the medical staff, without a single incident 
of theft or attempted theft.  
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Challenges 
The Technological Environment 
 The second segment of the screening process, management of results and 
follow up care, proved to be more challenging. The two clinics participating in this 
project differed markedly in their IT resources and infrastructure.  Technology 
barriers were: 1) technology environment and culture, and 2) integration of systems, 
including EHR integration. Clinic A had limited wireless connectivity, limited onsite IT 
support, and no EHR.  Clinic B had a sophisticated technological environment with IT 
support and an EHR.  Both clinics presented different challenges to the 
implementation of electronic screening on tablets, for opposite reasons.  Staff 
members at Clinic B felt comfortable using the tablet technology and helping patients 
use it.  Because they were so used to sophisticated technology, they expected a 
high level of functionality and a fast-paced technological workflow.  They were 
frustrated when there were the inevitable “glitches” or interruptions involved in 
introducing a new technology.  Staff at Clinic A was unused to technology in the 
clinic environment, as their exposure to health IT was limited, and were comfortable 
using paper and hard copy for most aspects of clinical operations and charting.  The 
introduction of an electronic tablet required a paradigm shift for them, and a shift in 
their skill sets, interactions with patients, and clinic processes.  
The second barrier to smooth implementation of this technology was the clash 
between the clinical IT infrastructure (e.g., wireless connectivity, EHRs, scheduling 
software) and the portable tablets and screening software.  While data were 
generated on the portable device, these data were stored on clinic servers, and Wi-
Fi was required by the tablets to function.  Both clinics had limited wireless networks 
of insufficient reliability to support the tablet technology.  The improvement of these 
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networks was a low priority for IT because clinic functioning was based on a wired 
network and wireless malfunction did not impede other clinical processes.  
Additionally, discrepancies in the interface of clinical and tablet software created 
repeated malfunctions in the communications between tablet devices and 
server/databases, leading to many days of tablets being unusable.  
Challenges in the interface of technologies also affected the clinical workflow.  
In the proposed workflow, providers were instructed to log in to the risk-screening 
database via a computer desktop icon.  In Clinic A, the desktop systems were old 
enough that their software was not compatible with the tablet screening software.  
Thus, it became impossible for providers to reliably log onto the risk screening profile 
for patients, and this process was eventually abandoned, making the data 
transmission to providers in Clinic A inoperable.  For Clinic B, the technology barrier 
was caused by the difficulty and expense of integrating data generated by the tablets 
seamlessly into the EHR.  This presented an issue in workflow for the staff of Clinic 
B, when the additional step of an MA entering screening results into the EHR 
became necessary, reducing efficiency and increasing frustration.   
The “Now What” Problem 
  The clinical resources were different between the two research sites, but both 
staffs expressed concern about three issues once patients had completed the 
screening:  
1. Talking to patients about difficult subjects. At the introduction of the risk-
screening process, many providers expressed some apprehension about 
talking with clients about difficult topics like a patient’s experience of domestic 
violence, alcohol abuse, depression symptoms or financial difficulties.  They 
reported that they sometimes felt ill prepared to discuss topics that were once 
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beyond the purview of a primary care visit (for example, food insecurity), but 
that they felt were crucial to patient health.   
2. Providing referrals based on patients’ newly discovered risks. Lack of referral 
resources for patients with limited financial or insurance options also proved 
to be a consistent source of frustration for providers.  Clinic A, though part of a 
larger hospital system, had few resources for behavioral health referral that 
were available to their publically insured or uninsured patients without a long 
wait for an appointment. Clinic B had integrated behavioral health and some 
dental resources, which alleviated a major referral burden. However, there 
were few obvious resources to address problems like food insecurity or 
specialist referral.  When staff at Clinic B was able to identify some community 
resources for patients, providers reported feeling better able to address the 
risks identified by the screening tool.  Staff at both clinics also expressed 
frustration at often being unaware if patients had seen community providers 
and being unable to access information about the disposition of those 
referrals if the provider had not contacted them directly. 
3. Insufficient time during clinical visit.  Providers universally articulated the 
challenges of addressing multiple serious and perhaps chronic medical and 
psychosocial issues illuminated by the screening within a 15-minute 
appointment in which they must also address the presenting issue, like an ear 
infection or diabetes management. 
Challenges in Staffing and Workflow 
Workflow challenges constituted the third barrier to implementation related to: 
1) who would do what and when, 2) staff turnover and learning curve, and 3) limited 
time.  Research project staff worked with medical staff at both clinics to identify a 
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workflow for the implementation of screening process based on the differences in 
environment and staffing.  Despite that, staff in both clinics were concerned about 
which groups of personnel would be responsible for which segments of the 
screening process and how patients and tablets would be “handed off” from one 
group to another, particularly if some segments of staff felt workflow in this project 
(and other areas of clinic work) to be inequitable.  Their concerns about clinical 
resources, and the effect of limited resources, directly affected the implementation of 
the screening tool.  Clinical providers at both sites were routinely double or triple 
booked for patient appointments and reported needing additional nursing support.  
Providers at both clinics reported that their patients were high need, with complex 
sets of problems, and that they didn’t have enough time to attend to these needs 
adequately.  Both clinics also reported needing additional front desk resources, as 
existing staff felt overburdened by registering patients for appointments, taking 
phone calls, and attending to provider and patient requests, while also managing the 
tablet distribution and collection.   
Clinic A experienced a reduction in overall staffing during the course of the 
implementation due to budget constraints, and then experienced a change of clinical 
leadership, both of which caused additional stress at all levels of the clinic staff.  
Additionally, Clinic A served as a teaching clinic with students rotating on a regular 
basis, resulting in a lack of consistent providers to train about the screening tool 
procedures.  
Conclusion 
This pilot project demonstrated that it is possible to implement an mHealth risk 
screening intervention with a medically underserved, urban population, with some 
caveats.  Screening administration (segment one) was successful in both clinics, 
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despite very different clinical environments that share a common thread of serving 
urban, publicly insured patients.  Given the barriers encountered during 
implementation, it could be argued that these types of technology-based 
interventions should not even be attempted in resource- or technology-poor 
environments.  However, the two clinics in which this project was piloted are 
representative of urban community clinic environments, and we propose that this is 
where the neediest patients seek care and where health disparities are most likely.  
This makes the implementation of innovative technologies in screening, prevention, 
and chronic disease management and care coordination even more crucial.  This 
pilot project identified technological barriers that can be addressed in future 
implementation in these settings (see below). 
This project also demonstrated that electronic screening based on patient 
reported outcomes offers new information about patient risk for chronic diseases, 
information that is otherwise challenging to capture efficiently and effectively.  This 
project proposes one method for providing comprehensive screening to meet USPTF 
guidelines in a non-biased and evidence-based way, with fewer screening burdens 
to providers and more patient involvement.  Doing so will provide traditionally 
marginalized patients with more opportunity to receive preventive care or treatment 
for complex diseases, thus potentially addressing health disparities influenced by 
provider/staff attitudes or biases and differences in resource distribution.  
 While obtaining the screening data was the smoothest component of the 
project, getting that screening data into the exam room for use in the patient 
encounter proved to be challenging.  Several anticipated barriers to the 
implementation of this project (stolen tablets or patients not knowing how/wanting to 
use tablets) turned out to be unfounded.  Other barriers that we had either 
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inadequately prepared for or had not expected became difficult obstacles.  Several 
recommendations have emerged as a result, and are discussed in more detail in 
Chapter Six: 1) Care pathways and clinic resources need to be developed for every 
risk dimension; 2) The technology used needs to be very stable and seamlessly 
integrated into existing clinical IT structures; 3) “Champion” staff members and 
pockets of resistance to the process need to be identified and addressed; 4) All 
levels and segments of clinic staffing need to participate in the development of an 
effective workflow; and 5) Nursing and nursing paraprofessionals can be empowered 
to act on the recommendations generated by this type of screening intervention via 
standing orders supervised by PCP staff. 
Though this project was challenged by the rapid technological innovation and 
adoption that made some of the tablet technology and clinical IT systems 
incompatible, there is also a philosophical barrier between the mHealth and clinic 
technological systems.  Health care IT has historically been oriented to protecting 
data, rather than facilitating access to data from external sources, for fear of 
vulnerability.  Introduction of a new technological process in which portable mHealth 
devices (like tablets) must work with healthcare IT infrastructure or send to or receive 
data from IT infrastructure represent a growing challenge, particularly in clinical 
settings with disparities in access to technological innovation and support. As 
technology continues to be more integrated into clinical operations, and as primary 
care patients present with more complex chronic diseases and their sequelae 
(Hamine et al., 2015; Ward et al., 2014), screening methods that reduce staff time 
and effort, while leveraging the experience of patients, provide an opportunity for 
safety net primary care clinics to address the charge of preventive services for 
populations that have been traditionally underserved.
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CHAPTER SIX:  Conclusion 
 
The overarching goal of this project was to develop and deploy an innovative 
technology platform to assess patient-reported risk factors with the aims of improving 
patient outcomes by making results available to clinicians at the point of the 
encounter. The three studies presented in this dissertation offer a number of key 
insights regarding the potential benefits of, and challenges associated with, the use 
of mobile health technologies to assess patient risk in clinical settings.   
Previous efforts to screen patients in these settings have been much more 
limited in several respects.  First, they have largely been focused on conditions like 
cardiovascular disease or diabetes for which clinically assessed disease markers are 
required.  Second, they have typically focused on one or two risks or conditions and 
thus have not been capable of providing a comprehensive portrait of patient risk.  
Third, the methods employed to assess patient risk – typically paper and pencil 
questionnaires – have made it difficult to use the information collected in the clinical 
encounter.  In this innovative project we addressed the weaknesses of previous 
studies by collecting self-reported data on patient health history, behavioral health, 
psychosocial risk factors, and health-risk behaviors in a comprehensive way using a 
tablet-based instrument that could be scored immediately and made available to 
primary care providers during a clinical visit and then offered to patients via a risk-
report card with proposed evidence based actions consistent with existing clinical 
pathways at the clinical site.  Our results offer new information about levels of risk in 
medically under-served, urban populations, challenges to follow up care for 
behavioral health conditions, and challenges and opportunities when implementing 
new technologies and screening protocols in safety-net settings.   
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 One of the most important findings from this research involved the high levels 
of unrecognized and undiagnosed risks and conditions in this patient population.  
While many of the risk dimensions and medical or behavioral health conditions for 
which we screened have not had reliable prevalence rates in this population, the 
estimates we obtained by reviewing patients’ medical charts grossly underestimated 
the level of risk.  When compared with data from the chart review, screening results 
demonstrated that these patients have statistically significantly higher rates of risk on 
every dimension, with rates of depression (32.1%), PTSD (32.3%) and dental risk 
(55.6%) much higher than has previously been reported in the literature (Alegría et 
al., 2008; Alim et al., 2006; Ani et al., 2008; Montero et al., 2003).  Most striking were 
findings involving PTSD, which was not observed in any of the charts of control 
patients but was observed in one third of patients completing the screening.  
Screening results also revealed that most patients were struggling with multiple risk 
factors:  the vast majority of screened patients had two or more risks, a stark 
contrast to the results of the chart review which revealed the majority of patients as 
having zero risk factors.  We also demonstrated that certain risk factors were 
statistically significantly associated with one another: depression with PTSD, and 
domestic violence with basic needs, which is consistent with syndemic theory of the 
excess burdens of co-morbid conditions (Singer & Clair, 2003).  Understanding how 
risks are associated and clustered can increase provider efficiency and accuracy in 
identifying and anticipating risk.  This screening tool yields a more comprehensive 
and reliable risk profile for patients served by the medical safety net and, by enabling 
providers to identify and treat comorbid conditions, has the potential to improve 
treatment outcomes. 
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 This study also demonstrated, however, that screening for these conditions is 
necessary but insufficient to improve health outcomes.  Identified rates of alcohol 
abuse, PTSD, and depression were statistically significantly higher in the intervention 
population compared with the control group, and the majority of those identified had 
not previously been identified with the condition.  When intervention patients were 
identified with these conditions, rates of treatment in the form of follow-up 
appointments, prescription and referral, though higher than in the control group, 
remained relatively low.  Even with the screening tool, 0 patients identified with 
alcohol abuse received follow up care, and only 18.2% of patients identified by 
screening with depression symptoms and 6.3% of those with PTSD received follow 
up care in the six months after the target appointment.  This held true even though 
this clinic had access to integrated behavioral health care.  This result spotlights 
some of the choke-points in the identification-treatment pathway where patients are 
“lost” or drop out and may indicate areas in which clinics must make strategic efforts 
to develop more robust clinical pathways or engage patients in care.    
  
This project also illustrated the obstacles to implementing new processes into 
clinics, particularly those involving new information technologies, and revealed the 
scarcity of resources available to safety net practices to either address patients’ 
needs within the clinic or refer to specialty care.  Ironically, what we worried about 
most in designing this intervention -- theft of tablets, minimal patient acceptance -- 
proved to be no challenge at all.  In fact, patients were quite willing to contribute 
information about their symptoms, behaviors, and experiences in an effort to assist 
providers in delivering higher quality, more personalized care.    
Challenges and Limitations 
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Still, the technological barriers to implementation considerably impacted the 
success of the project.  As a result of these technological challenges, there were 
major discrepancies between the design of this project and its actual implementation.  
In practice, the technology interface in both clinics was not reliable enough to 
operate uninterrupted during the entire intervention period.  This issue required 
continual changes to the intervention protocols impacting the identification of eligible 
patients, the continuity of screening periods, and the ability of providers to review 
results.  
These challenges resulted in “mis-matched” processes and datasets between 
the clinical sites.  In Clinic A, we collected a large volume of screening data, but had 
incomplete data on eligible patients for recruitment, and no chart review data for 
screened patients.  Technology challenges also prevented providers from seeing 
screening results, which meant they were unable to identify and address risks in 
screened patients, although the aggregate data were helpful in enabling Clinic A to 
identify areas of need and in overall risk surveillance of their patients.  In Clinic B, the 
interface between the wireless infrastructure in the clinic and the tablet technology 
made stability of the tablets unpredictable.  As a result, some patients who could 
have been screened were not, and some results that should have been seen by the 
provider could not be entered into the EHR, while the MAs entered the remaining 
results into the EHR.  These workflow and technology difficulties illuminated the 
challenges of clinics where demand is high and assets (time, staffing, technological 
infrastructure, referral resources) are low.  
As a consequence of these and the other barriers discussed in Chapter Five, 
this project had several limitations, which included:  use of some screening questions 
that lacked data on validity, limited samples of patients, lack of data on eligible 
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patients, and potential lack of generalizability to other safety net clinical 
environments.  Risk dimensions selected for inclusion in the development of the 
screening questionnaire were determined by a combination of most common issues 
seen in this population and areas of risk of particular interest to the clinical 
leadership.  While every effort was made to select validated instruments, there were 
some risk dimensions (like dental risk and basic needs) where a validated instrument 
did not exist.  Instead, focus groups and counsel with experts in the field resulted in 
selection of screening questions determined to represent the state of the art for given 
risk dimensions.   
There were also substantial difficulties in obtaining charts on all of the patients 
in the intervention condition.  Given the paper medical records and the challenge in 
requesting the volume of charts for all intervention patients from Clinic A, the number 
of charts available for review for intervention patients was limited and produced a 
smaller sample size than expected for several of our groups.  We were not able to 
analyze the follow up care received by patients after the screening at both sites.  
Some of the statistical tests we had proposed using to illuminate racial and ethnic, 
gender, and socioeconomic differences were limited in their power and not 
generalizable.  This was further complicated by the low incidence of some of the risk 
dimensions (e.g. osteoporosis and fall risk). 
Additionally, given difficulties in technology and workflow, we were unable to 
screen every patient who came into the clinics.  By accessing scheduling data we 
estimated that approximately 50% of eligible patients seen during the intervention 
period at Clinic B were not screened; however we could not obtain estimates of 
eligible patients for Clinic A.  We cannot, as a result, guarantee that there were not 
statistically significant differences between patients who were screened and those 
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who were not, although the patients we screened were demographically similar to 
the general demographic profiles of the clinics. 
Finally, these two clinics may not represent typical safety net primary care 
setting in the United States, as they fell on opposite sides of a spectrum in terms of 
team based care, integration of services, and technological infrastructure.  The 
profile of a typical safety net primary care center likely has some structural and 
staffing elements of both of our clinical sites.  While we were successful in screening 
a large number of patients, both clinical sites had difficulty with the volume and 
complexity of the resources required to address patients’ needs, given the lack of in-
house, specialty, or community resources. 
  
Our results have important implications for current trends in healthcare 
delivery in the US.  The Patient Centered Medical Home (PCMH), the nation’s 
fastest growing and most widely supported practice transformation model in primary 
care, aims to create a single place for individuals to receive care that is “what 
patients want it to be” by emphasizing comprehensive and coordinated medical care 
with higher quality and lower costs (NCQA, 2015; Rosenthal, 2008; The American 
College of Physicians, 2006; Williams, Jackson, & Powers, 2012).  Technological 
screening platforms like the one described here can provide patient-reported 
outcomes data to inform targeted interventions and care coordination to improve 
health outcomes at both the individual and population level, which are key standards 
for Patient Centered Medical Home (PCMH) certification (Higgins & Green, 2011). 
Yet, while this screening intervention was successful in identifying risk 
conditions in this population, it also illuminated some of the more complex aspects of 
identifying risk without identified resources to which to refer patients.  Staff members 
Implications 
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at both clinics understood USPTF guidelines on screening and were committed to 
delivering preventive care to patients, but also expressed discomfort at some of the 
ethical dilemmas of identifying risk factors for which there were insufficient referral or 
specialty resources that could support patients.  Whether it was for dental services or 
depression treatment, universal screening projects of this kind expose the ethical 
and practical difficulties of identifying problems for which there are often limited or 
problematic solutions for patients in safety-net primary care (Betancourt et al., 2004; 
Braveman & Gruskin, 2003; Kokanovic et al., 2009; Spitzer, 2005; J. S. Weissman et 
al., 2005).  Screening programs have potential to identify disparities and can help 
target key clinic resources over the long term, but can also lead to a sense of 
frustration for providers and disengagement for patients, as well as exposing clinics 
and providers to legal risk.  In this project, establishing care pathways and identifying 
key community and clinic resources ameliorated some of these concerns, but the 
paucity of specialty care available to patients with public or limited insurance remains 
a substantial concern. 
As this project creates a fuller profile of the complexity of patients seen in 
these types of safety net urban practices, and identifies needs beyond the clinic, it 
also illuminates the need to develop efficient and effective critical care pathways 
within the clinic, or associated with the clinic.  In urban safety net primary care with 
scarce personnel and structural resources, preventive service delivery creates an 
even greater burden (Fiscella & Holt, 2007; Fiscella & Epstein, 2008; Partnership for 
Prevention, 2007), particularly for patients with multiple medical and behavioral 
health conditions (Gerteis J, Izrael D, Deitz D, LeRoy L, Ricciardi R, Miller T, Basu J, 
2014; Ward et al., 2014).  Using technologies and protocols developed during this 
project, screening results could assist interprofessional teams to address pressing 
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health issues that may not emerge during the clinical encounter.  The provider team, 
and particularly the nursing or MA staff, caring for a particular patient could be 
empowered (using protocols and standing orders) to identify and constructively 
engage patients at risk of various conditions, with information suggesting clinical 
pathways, evidence based evaluation strategies and site specific resources  (D. 
Anderson et al., 2012; Institute of Medicine, 2010).  This would address patient 
needs without additional burden for physicians, while allowing other members of 
healthcare teams to work at the “top of their licenses” (NACNEP, 2012).  
 Tablet-based screening protocols also have potential to address some of the 
growing fragmentation and disruption in primary care.  While the ACA has provided 
more Americans than ever with insurance, it is not clear that more people will enter 
into traditional relationships with a primary care practice or an individual provider.  
With a growing emphasis on non-traditional care environments, like urgent care 
centers and pharmacy-based clinics, the fragmentation of healthcare and challenges 
to patient-provider rapport are growing concerns.  The largest pharmacies and 
retailers in the US have announced ambitious plans to provide basic healthcare 
services on-site (Diamond, 2-14; Japsen, 2014; Redman, 2014).  Due to concerns 
over their potential to foster further fragmentation of healthcare and a movement 
away from physician-led care teams that establish durable relationships with 
patients, both the American Academy of Pediatrics and the American Academy of 
Family Physicians have issued formal statements of opposition or non-endorsement 
(AAFP, 2014; AAP, 2014).  For people in traditionally underserved populations, this 
is an even more important concern, as they are more likely to change residences 
often, live in institutionalized settings like prisons or supportive housing, and have 
various other disruptions in their healthcare relationships.  Implementing electronic 
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screening is one method of leveling the playing field for patients that present as 
“New Patients” continually, by taking a snapshot of patients’ health risks that may be 
complicating other factors of their lives, both medically and psychosocially, and by 
creating an electronic record of care.  These are concerns that might not be 
discussed in an urgent care visit for something like bronchitis, but might be crucial to 
connecting a patient to more supportive and holistic care.   
 
Even given the limitations stated above, lessons learned in the course of this 
project represent the types of challenges and constraints that might be seen in a 
real-world attempt to implement universal screening, new mHealth technologies, or 
complex care management of patients with multiple chronic diseases.  Several 
recommendations have emerged from this project:  
1) Critical care pathways, complete with a list of resources and potential 
providers to whom to refer, need to be developed and made available 
to all providers at the outset of the implementation;  
2) The technology used needs to be very stable and seamlessly 
integrated into existing clinical IT structures, so that tablets work 
reliably, wireless capacity is allocated for communication between 
tablets and screening database/repository, and screening results are 
presented to providers easily in seamless merge with EHR.  Apparatus 
of data collection may include hardwired kiosk system, or accessibility 
from smart phones, computers, or patient portals;  
3) “Champions,” staff members who are enthusiastic about the 
contributions of screening to the clinical enterprise, willing to be point 
persons for staff concerns and questions, and empowered to demand 
Recommendations 
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adherence to screening protocols when clinic staff are “stressed” or 
overburdened, must be identified;  
4) Nursing support staff or MAs may be the people best qualified to 
address the challenges posed by this type of intervention because of 
their primary role in preventive services, care coordination and patient 
contact.  These staff members could be trained to review risks and 
determine next steps based on clinical guidelines and make referrals 
via standing orders, of which the primary care provider could be 
informed, and could countersign and intervene if necessary; and 
5) Workflow processes should be established with representatives at all 
levels of clinic staff to adequately assess and address staffing shortfalls 
or “stress points”, especially so that these processes can be flexible in 
response to changing care environments.  
 
In addition to its direct impact on patient care, innovative technologies and 
prevention projects such as this one have the potential for a much broader public 
health impact.  Comprehensive risk data, like those collected in this project, can 
pinpoint unaddressed areas of risk that can then inform targeted interventions to 
improve health outcomes at both the individual and populations levels, which should 
lead to a further reduction in racial and socioeconomic health disparities.  
Furthermore, if these types of screening interventions are administered recurrently, 
patients and populations could be tracked over time to monitor and assess changes 
in risk, health-promoting behaviors, and health outcomes.  These data also serve to 
document and support best practices and innovative quality improvement initiatives 
in the treatment of chronic disease and behavioral health disorders in populations at 
Conclusion 
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risk, while also meeting certification requirements from the Joint Commission and 
National Committee on Quality Assurance PCMH on data collection and risk 
surveillance.  
This project demonstrates the need to obtain crucial information from patients, 
to give providers more holistic information about patients, to establish care pathways 
and standing orders to capitalize more efficiently on provider time at all levels, and to 
identify and develop resources within primary care environments and beyond to 
address the complex needs of patients in ways that that are culturally responsive, 
quality-focused, efficient, and effective.  These types of innovations will support an 
evolving healthcare system that relies more on technology, fosters a team-based 
approach, and coordinates complex care, all with the aim of improving the health of 
traditionally underserved and marginalized populations.
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Chapter Two Tables and Figure 
 Clinic B  Clinic A Control Intervention Control v.   
Intervention 
Clinic A v  
Clinic B  Control  Inter.  Control Interv   
 N=129  N=146  N=131 N=327 N= 260 N=473 P value P value 
 %  %  % %     
Gender          .38 .29 
Male 31  35.6  43.5%  36.4 37.3 36.2   
Female 69  64.4  55.7  63.6 62.3 63.8   
Age          .00 .00 
18-24 7.8  16.4  4.6  13.1 6.2 14.2   
25-29 4.7  12.3  5.4  8.3 5.1 9.5   
30-39 27.1  28.1  13.8  15.3 20.6 19.2   
40-49 24  17.8  22.3  22.6 23.3 21.1   
50-64 25.6  19.9  34.6  30.3 30.4 27.1   
65+ 9.3  5.5  19.2  10.4 14.4 8.9   
Race/Ethnicity     N=65*   N=191*  .00 .00 
White 33.3  24.7  13.1  11.3 23.6 15.4   
African American 11.6  13.7  66.2  55.7 30.4 42.5   
Hispanic/Latino 52.7  59.6  30.8  25.1 44.5 35.5   
Other 2.3  2.1  --  8.3 1.6 6.1   
Insurance     N=23*   N=152* N=146* .13 .00 
Public 57.4  48  69.6  NA 59.2 47.9   
Private 14.7  24  30.4  NA 17.1 24   
Self-Pay 27.9  28    NA 23.7 28.1   
Patient Status          .43 .69 
Existing 91.5  89  91.4  NA 91.4    
New 8.5  11  8.6  NA 8.6    
*These variables were not always recorded in paper chart reviews in Clinic A, and so these data were not available for all patients, and thus 
percentages are adjusted.  Note: Significance is determined by chi-square analysis.  Statistically significant p values are noted in bold italics 
 
 
Table 1.  Patient Demographics by Experimental Group and Clinics 
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 Clinic A Clinic B 
Experimental Group Problem in 6 months 
Prior 





None Screening Results only 
via screening database 
 EHR  
o Any mention of 
problem in 
Problem List or 
notes in any 
appt in last six 
months 
 Follow-up care 
recommended 
 Screening Results 
via database 
 EHR 
o Screening results 
noted by MA 




 Paper Chart 
o Any mention of 
problem in 
Problem List or 
notes in any 
appt in last six 
months 
o Follow-up care 
recommended 
 Paper Chart 
o Any mention of 
problem in 
Problem List or 
notes 
o Follow-up care 
recommended 
 EHR  
o Any mention of 
problem in 
Problem List or 
notes in any 
appt in last six 
months 
 Follow-up care 
recommended 
 EHR  
o Any mention of 
problem in 
Problem List or 
notes 




Table 2.  Measures-Data Source Table 
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Table 3.  Health Domains and Risk Screening Guidelines and Tools 
Health Domain Screening 
Name 
Screening Questions Reference 




AUDIT-C  Did you have a drink containing alcohol in the past 
year? 
 How often do you have a drink containing alcohol?  
 How many drinks containing alcohol do you have on 
a typical day of drinking?  
 How often do you have five or more drinks on one 
occasion?  
Bohn, M. J., Babor, T. F., & Kranzler, H. R., 1995; 
Garg, Butz, Dworkin, Lewis, & Serwint, 2009; 
Reinert & Allen, 2007 
 
Basic Needs   Do you and your family have enough healthy food to 
eat? 
 Do you have enough money to heat your home this 
winter? OR Thinking back to last winter, did you 
have enough money to heat your home? 
 Are you behind in paying your rent or mortgage? 
The Columbus House staff and clients, New 
Haven, CT; Bhat & East, 2015; Davila, Rajan, & 
Baron, 2006; Fiscella, Franks, Gold, & Clancy, 
2000; Garg et al., 2009 
Colonoscopy   Have you had a colonoscopy in the last ten years? Emmons et al., 2009; Murff, Peterson, Greevy, 
Shrubsole, & Zheng, 2007; Pox et al., 2009 
Demographics   How old are you? 
 What is your gender? 
 What is your race?  
 What is your ethnicity?  
 Are you married or living with a partner?  
 Did you graduate from high school? 
 
Dental   Has it been longer than one year since you’ve seen 
a dentist? 
 Do you have any pain in your mouth? 
 Do your gums bleed when you brush your teeth? 
UCONN Health Center Dental faculty and students, 
Farmington, CT; Montero et al., 2003; Tang et al., 
1997; U.S. Department of Health & Human 
Services, 2000 
Depression PHQ-9  Over the last 2 weeks, how often have you been 
bothered by Little interest or pleasure in doing 
things 
 Over the last 2 weeks, how often have you been 
bothered by Feeling down, depressed, or hopeless   
Kroenke & Spitzer, 2002; Merz, Malcarne, Roesch, 
Riley, & Sadler, 2011 
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 Over the last 2 weeks, how often have you been 
bothered by Trouble falling or staying asleep, or 
sleeping too much   
 Over the last 2 weeks, how often have you been 
bothered by Feeling tired or having little energy 
 Over the last 2 weeks, how often have you been 
bothered by Poor appetite or overeating   
 Over the last 2 weeks, how often have you been 
bothered by Feeling bad about yourself — or that 
you are a failure or  
 Have let yourself or your family down  
 Over the last 2 weeks, how often have you been 
bothered by Trouble concentrating on things, such 
as reading the  
 Newspaper or watching television  
 Over the last 2 weeks, how often have you been 
bothered by Moving or speaking so slowly that other 
people could have  
 Noticed?  Or the opposite — being so fidgety or 
restless  
 That you have been moving around a lot more than 
usual  
 Over the last 2 weeks, how often have you been 
bothered by Thoughts that you would be better off 
dead or of hurting  
 Yourself in some way  
 If you checked off any problems, how difficult have 
these problems made it for you to do your work, take 




HITS  How often does your partner: Physically hurt you  
 How often does your partner: Insult or talk down to 
you  
 How often does your partner: Threaten you with 
harm  
 How often does your partner: Scream or curse at 
you  






Falls   Have you fallen in the last year? 
 Can you stand on one leg for longer than five 
seconds without support? 
Okumiya et al., 1998; Shumway-Cook, Brauer, & 
Woollacott, 2000; Shumway-Cook et al., 2009 
General Health   Overall, how would you rate your health?  
Obesity BMI  How tall are you in feet and inches? 
 How much do you weigh in pounds? 
NIH, 2000; World Health Organization 
Osteoporosis   Women who are over 65 and White at particular 
Risk 
McLeod & Johnson, 2009 
PTSD My Mood 
Monitor 
 Over the last 2 weeks, how often have you been 
bothered by nightmares or flashbacks 
 Over the last 2 weeks, how often have you been 
bothered by feeling jumpy or startled easily 
 Over the last 2 weeks, how often have you avoided 
places that strongly remind me of a bad experience 
 Over the last 2 weeks, how often have you been 
bothered by feeling dull, numb, or detached 
Gaynes. B., DeVeaugh-Geiss, J., Weir, S., Gu, H., 
MacPherson, C., Schulberg, H., Culpepper, L., & 
Rubinow, R., 2010 
 
Sexual Health   How many sexual partners have you had in the last 
year? 
 How often do you use condoms with your sexual 
partner(s) when NOT trying to get pregnant? 
American Academy of Family Physicians, 2009; 
American Academy of Family Physicians, 2015 









Figure 1.  Flow Chart of Clinic B Patients during Study Period 
Eligible Patients 
N=314 
- Patients seen by the 
two study PCPs for 
medical 
appointments from 
Sept-Dec 2013 on 
screening days 
 





Patients seen in the clinic 
from Sept-Dec 2013 who: 
- Did not have medical 
appointments (i.e., 
received    
immunizations, BP or 
A1C checks, diabetic 








Chapter Three Tables and Figure 








Control Interv Control Interv Control Interv 
 n= 131 n= 327 n= 129 n= 146 n=260 n=473 Sig. 
 % % % % % %  
Alcohol 4.6 2.4 2.3 8.2 3.5 4.2 .000 
Basic 
Needs 
2.3 47.7 1.6 39 1.9 45 .000 
BMI 16 55.4 20.9 28.8 21.5 47.1 .000 
Colonosc
opy 
6.9 20.8 5.4 9.6 6.2 17.3 .000 
Depressio
n 
13 33.3 7.8 29.5 10.4 32.1 .000 
DV 0 4 0 6.2 0 4.7 .000 
Falls 3.1 5.2 2.3 2.1 2.7 4.2 .000 
Osteopor
osis 
0 0 .8 5.5 .4 1.7 .000 
PTSD 0 34.3 0 28.1 0 32.3 .000 
Smoking 9.2 30.9 21.7 28.1 15.4 30 .000 
STI Risk 3.1 4.9 .8 1.4 1.5 3.8 .009 
Dental .8 53.8 1.6 59.6 1.2 55.6 .000 
Note: Statistical significance of control vs. intervention patients determined using 
logistic regression models, controlling for site, condition, gender, age, race. 
  
 
Table 4.  Frequencies of Risk Conditions 
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Note: Statistically significant differences determined by Chi-Square analysis are bold 
and italicized. 
  
Table 5.  Racial and Ethnic differences in prevalence of disorders in the 
intervention group  
Disorder White African 
American 
Hispanic Other Sig. 
 n=73 n=201 n=168 n=29 p-value 
Alcohol 12.3 2.5 5.4 3.4 .08 
Basic Needs 41.1 47.3 42.9 51.7 .67 
BMI 35.6 57.7 41.7 0 .00 
Colonoscopy 16.4 22.4 13.1 20.7 .06 
Depression 35.6 25.4 39.3 34.5 .03 
Dental 63 51.7 58.3 48.3 .29 
DV 2.7 1.5 8.3 6.9 .01 
Falls 4.1 5.5 2.4 10.3 .16 
Osteo 2.7 0 4.2 0 .02 
PTSD 30.1 27.9 37.6 37.9 .22 
Smoking 42.5 28.4 26.2 31 .08 












1 27.3 20.7 
2 11.9 22.4 
3 3.5 17.5 
4 .8 18.6 
5 0 10.8 
6 0 4.0 
7 0 1.3 
8 0 .2 
9 0 0 
10 0 .2 
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BMI NA 0.763 0.823 0.632 0.003 0.004 0.808 0.072 1 0.308 0.013 0.383 
Smoking 0.763 NA 0.005 0.435 0.000 0.002 0.147 0.113 0.804 0.159 0.841 0.485 
Alcohol 0.823 0.005 NA 0.035 0.226 0.228 0.224 1 0.586 0.251 0.178 0.001 
STI 0.632 0.435 0.035 NA 0.304 0.306 0.336 1 0.547 0.469 0.47 0.007 
Depression 0.003 0.000 0.226 0.304 NA 0.000 0.436 0.446 0.627 0.113 0.000 0.36 
PTSD 0.004 0.002 0.228 0.306 0.000 NA 0.436 0.447 1 0.093 0.002 0.242 
Colonoscopy 0.808 0.147 0.224 0.336 0.436 0.436 NA 0.034 0.062 0.113 0.903 0.396 
Osteoporosis 0.072 0.113 1 1 0.446 0.447 0.034 NA 0.041 0.31 0.079 1 
Fall Risk 1 0.804 0.586 0.547 0.627 1 0.062 0.041 NA 0.01 0.492 1 
Dental 0.308 0.159 0.251 0.469 0.113 0.093 0.113 0.31 0.01 NA 0.926 1 
Basic Needs 0.013 0.841 0.178 0.47 0.000 0.002 0.903 0.079 0.492 0.926 NA 0.003 
Dom Violence 0.383 0.485 0.001 0.007 0.36 0.242 0.396 1 1 1 0.003 NA 
Note: To adjust for multiple comparisons, the significance level was chosen to be 0.008, which control the false discovery rate at 5%.  Statistically significant 
p-values less than 0.008 are shown in bold and italicized. 




Note: Lines linking two risk factors or conditions reflect a statistically significant association after 
adjusting for multiple comparisons 
 
Figure 2.  Statistically Significant Associations between Pairs of Two Risk 
Factors/Conditions in the Intervention Group 
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Chapter Four Tables 
Experimental Group Problem in 6 months Prior Target Appointment Tx/FU 6 months following 
Intervention  EHR  
o Any mention of 
problem in Problem 
List or notes in any 
appt in last six months 
o Follow-up care 
recommended 
 Screening Results: 
o PHQ-9 
o My Mood Monitor 
o AUDIT-C 
 EHR 
o Screening results noted 
by MA 
o Follow-up care 
recommended 
 EHR 
o Any mention of problem 
in problem list or notes 
in any appointment in 6 
months post target apt 
o Any mention of problem 
in problem list or notes 
in any appt in six 
months post 
Control  EHR  
o Any mention of 
problem in Problem 
List or notes in any 
appt in last six months 
o Follow-up care 
recommended 
 EHR  
o Any mention of problem 
in Problem List or notes 
o Follow-up care 
recommended 
 EHR 
o Any mention of problem 
in problem list or notes 
in any appointment in 6 
months post target apt 
o Any mention of problem 
in problem list or notes 
in any appt in six 
months post  
 







   Not Screened 
       N=168 
Intervention v.  
Control 
Intervention 
Screened v.  Not 
Screened 
 N %  N %  N % P-values P-values 
Gender         .44 .75 
Male 40 31  52 35.6  57 33.9   
Female 89 69  94 64.4  111 66.1   
Age         .05 .2 
18-24 10 7.8  24 16.4  13 7.7   
25-29 6 4.7  18 12.3  22 13.1   
30-39 35 27.1  41 28.1  45 26.8   
40-49 31 24  26 17.8  35 20.1   
50-64 33 25.6  29 19.9  40 23.8   
65+ 12 9.3  8 5.5  13 7.7   
Race/Ethnicity         .38 .04 
White 43 33.3  36 24.7  26 17.3   
Af.-Amer.  
AmAmerican 
15 11.6  20 13.7  35 20.8   
Hisp./Latino 68 52.7  87 59.6  97 57.7   
Other 3 2.3  3 2.1  10 6   
Insurance         .13 .19 
Public 74 57.4  70 48  93 55.4   
Private 19 14.7  35 24  27 16   
Self-Pay 36 27.9  41 28  48 28.6   
Patient Status         .55 .38 
New 118 8.5  16 11  24 14.3   
Existing 118 91.5  130 89  144 85.7   
Note.   Significance determined by chi-square analysis.  Statistically significant p-values are in bold italics. 
Table 9.   Patient Demographics by Experimental Group (Clinic B) 
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Note.   Odds ratios and 95% confidence intervals were derived from logistic regression models with age as a covariate.   Because 
of the lack of PTSD cases identified in the control group, logistic regression analyses were conducted using the Firth correction.
Table 10.   Prevalence of Behavioral Health Problems in Target Appointment and in 6 Months Prior to Target Appointment  
(Clinic B) 
 
Target Appointment  6 Months Prior 















 % (n) % (n) OR (95% CI)  % (n) % (n) OR (95% CI) 
A Alcohol Abuse 8.2% (12) 2.3% (3) 3.50 (0.95, 12.92)  2.7% (4) 4.7% (6) 0.65 (0.17, 2.40) 
 Depression 29.5% (43) 7.8% (10) 5.33 (2.50, 11.33)  15.8% (23) 18.6% (24) 0.94 (0.49, 1.80) 




% Positive in Target 
Appointment 
(n=98) 
% of those identified 
that were new cases 
For those patients identified with the 
problem in the Target Appointment 
% in notes % in list 
 
% with follow 
up 
Alcohol Abuse 6.1% (6) 100% (6) 16.7% (1) 0 0 
Depression 33.7% (33) 78.8%(26) 39.4% (13) 9.1% (3) 18.2% (6) 
PTSD 32.7% (32) 96.9% (31) 12.5% (4) 6.3% (2) 6.3% (2) 
 Table 11.   Identification of Behavioral Health Problem and Follow up among those Identified with Behavioral Health Risks 
and whose Results were seen by Providers
 70 
Chapter Five Table 
 Recruitment Exclusions Screening Presentation to 
Provider 









waiting room; told 
to ask reception if 
any questions 
Provider accesses 
results via an icon 











s for follow-up 









None None None 










Tablet given to MA 









Table 12.   Proposed vs. Implemented Screening Process 
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